- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
December 4th, 2007
Consumer advocates and the biotechnology industry yesterday hailed a report on the Food and Drug Administration that outlines devastating inefficiencies at the agency and echoes what other groups have been complaining about for years.
Without the proper technology, the agency can't keep up with developments in emerging technologies such as nanotechnology or wireless health care, he said.
The report includes a recommendation for implementing an organizational and process structure, called an incubator for innovation, that supports regulatory work while bolstering internal science.
|Related News Press|
ANU invention to inspire new night-vision specs December 7th, 2016
Arrowhead Pharmaceuticals to Webcast Fiscal 2016 Year End Results December 7th, 2016
Journal Nanotechnology Progress International (JONPI), newest edition out December 7th, 2016